DelveInsight’s Plaque Psoriasis Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities and treatment options. 

The report also offers comprehensive insights into Plaque Psoriasis market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of market size forward. 

 

Some of the key highlights from the Plaque Psoriasis Market Insights: 

• According to National Psoriasis Foundation (NPF), more than 8 million Americans have psoriasis and is equally prevalent in males and females. 
• The most common form of psoriasis, affecting about 80 to 90 per cent of psoriasis patients, is plaque psoriasis.
• Plaque psoriasis is the most common form of the disease, affecting 80 per cent of those with psoriasis.
• At present, there is no cure in the Plaque Psoriasis market. 
• The Plaque Psoriasis Therapeutics market comprises topical agents such as moisturizers, vitamin D creams, topical retinoids, and medications such as TAZORAC®, Duobrii (Ortho Dermatologics), and coal tar. 
• TAZORAC (Allergan, Inc) Gel, 0.05%, and 0.1% is indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement. 
• Major players such as Bristol-Myers Squibb, Dermavant Sciences GmbH, Arcutis, Inc., Avillion LLP, and others are involved in developing therapies for the treatment and management of Plaque Psoriasis. These therapies are currently under different stages of development. 
• Key pipeline therapies in the Plaque Psoriasis market include Tapinarof (Dermavant Sciences GmbH), BMS986165 (Bristol-Myers Squibb), ARQ-151 (Arcutis, Inc.) and M1095 (Avillion LLP), among others.

 

Learn more by requesting for sample @ Plaque Psoriasis Market Landscape

 

Plaque Psoriasis: Overview 

Psoriasis is a common skin condition that speeds up the life cycle of skin cells. It causes cells to build up rapidly on the surface of the skin. The extra skin cells form scales and red patches that are itchy and sometimes painful. 

The characteristic signs and symptoms of psoriasis are small scaly, red bumps. These bumps generally join together into elevated plaques of skin and most often are visible on the elbows, knees, and scalp, although any area of skin can be involved. Frequently, these plaques are quite itchy. Rarely, most of the patient’s skin surface is affected.

 

Plaque Psoriasis Epidemiology Segmentation

The Plaque Psoriasis Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

• Psoriasis Prevalence 
• Plaque Psoriasis Prevalence 
• Severity Specific Plaque Psoriasis Prevalence 
• Diagnosed and Treatable Cases of Plaque Psoriasis

 

Visit for more @ Plaque Psoriasis Epidemiological Insights

 

Plaque Psoriasis Market 

Plaque Psoriasis Market size is expected to expand owing to the launch of several emerging therapies, key companies working in the space, rising prevalence, increment in R&D in the field, medical advancements happening in the Plaque Psoriasis market domain. 

 

Plaque Psoriasis Pipeline Therapies and Key Companies 

• Tapinarof: Dermavant Sciences GmbH
• BMS986165: Bristol-Myers Squibb
• ARQ-151: Arcutis 
• M1095: Avillion 

 

Plaque Psoriasis Market Drivers

• Rising prevalent population
• Technological advancements
• Emerging therapies 
• Extensive R&D

 

Scope of the Report

• 11 Years Forecast
• 7MM Coverage 
• Descriptive overview of Plaque Psoriasis, covering causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight into Plaque Psoriasis epidemiology and treatment in the 7MM
• Current and emerging therapies for Plaque Psoriasis 
• Plaque Psoriasis market drivers and barriers 

 

Key Questions Answered in the Report

• What was the Plaque Psoriasis market share (%) distribution in 2017 and how it would look like in 2030?
• What would be the Plaque Psoriasis total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Plaque Psoriasis market size during the forecast period (2017-2030)?
• At what CAGR, the Plaque Psoriasis market is expected to grow in 7MM during the forecast period (2017-2030)?

 

Table of Contents 

1	Key Insights
2	Report Introduction
3	Competitive Intelligence Analysis for Plaque Psoriasis
4	Plaque Psoriasis Market Overview at a Glance
5	Executive Summary of Plaque Psoriasis
6	Plaque Psoriasis Epidemiology and Market Methodology
7	Plaque Psoriasis Epidemiology and Patient Population
8	Plaque Psoriasis Patient Journey
9	Treatment Algorithm, Current Treatment, and Medical Practices
10	Key Endpoints in Plaque Psoriasis Clinical Trials
11	Plaque Psoriasis Marketed Therapies
12	Plaque Psoriasis Emerging Therapies
13	Plaque Psoriasis: 7 Major Market Analysis
14	Attribute analysis
15	Access and Reimbursement Overview of Plaque Psoriasis
16	KOL Reviews
17	Case Reports
18	Plaque Psoriasis Market Drivers
19	Plaque Psoriasis Market Barriers
20	SWOT Analysis
21	Disclaimer
22	DelveInsight Capabilities
23	About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.  

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/plaque-psoriasis-market